This issue of Hematology/Oncology Clinics, edited by Dr. Ursula Matulonis, will focus on Ovarian Cancer. Topics include, but are not limited to, Risk factors for ovarian carcinoma; Ovarian cancer pathology; Early detection and prevention strategies for ovarian cancer; Pathogenesis, genetics and genomics of high grade serous cancer; Pathogenesis, genetics and genomics of non-high grade serous cancers; Management and Treatment of newly diagnosed ovarian cancer; Management and Treatment of recurrent ovarian cancer; Treatment of rare epithelial ovarian tumors; Targeting DNA damage response and repair as a therapeutic strategy for ovarian cancer; Mechanisms of drug resistance in ovarian cancer; The status of and targeting the immune system in ovarian cancer: current and future approaches; Antibody drug conjugates; The role of angiogenesis in ovarian cancer pathogenesis and treatment; Management and understanding of acute and long term toxicities of patients with ovarian cancer; and Palliative Care of the advanced ovarian cancer patient.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Risk Factors for Ovarian Carcinoma - p. 891 9. Early Detection of Ovarian Cancer - p. 903 10. Frontiers in the Pathology and Pathogenesis of Ovarian Cancer: Cancer Precursors and "Precursor Escape" - p. 915 11. Pathogenesis, Genetics, and Genomics of Non–High Grade Serous Ovarian Cancers - p. 929 12. Diagnosis and Treatment of Ovarian Cancer - p. 943 13. Management and Treatment of Recurrent Epithelial Ovarian Cancer - p. 965 14. Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer - p. 983 15. Targeting DNA Damage Response and Repair as a Therapeutic Strategy for Ovarian Cancer - p. 997 16. Treatment of Rare Epithelial Ovarian Tumors - p. 1011 17. Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer - p. 1025 18. Targeting Angiogenesis: Taming the Medusa of Ovarian Cancer - p. 1041 19. Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer - p. 1057 20. Living Through Ovarian Cancer Treatment: Acute and Long-Term Toxicities of Chemotherapy for Advanced-Stage Disease - p. 1073 21. Palliative Care and Symptom Management for Women with Advanced Ovarian Cancer - p. 1087
No hay muestra disponible
No hay ficha técnica disponible
This issue of Hematology/Oncology Clinics, edited by Dr. Ursula Matulonis, will focus on Ovarian Cancer. Topics include, but are not limited to, Risk factors for ovarian carcinoma; Ovarian cancer pathology; Early detection and prevention strategies for ovarian cancer; Pathogenesis, genetics and genomics of high grade serous cancer; Pathogenesis, genetics and genomics of non-high grade serous cancers; Management and Treatment of newly diagnosed ovarian cancer; Management and Treatment of recurrent ovarian cancer; Treatment of rare epithelial ovarian tumors; Targeting DNA damage response and repair as a therapeutic strategy for ovarian cancer; Mechanisms of drug resistance in ovarian cancer; The status of and targeting the immune system in ovarian cancer: current and future approaches; Antibody drug conjugates; The role of angiogenesis in ovarian cancer pathogenesis and treatment; Management and understanding of acute and long term toxicities of patients with ovarian cancer; and Palliative Care of the advanced ovarian cancer patient.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Risk Factors for Ovarian Carcinoma - p. 891 9. Early Detection of Ovarian Cancer - p. 903 10. Frontiers in the Pathology and Pathogenesis of Ovarian Cancer: Cancer Precursors and "Precursor Escape" - p. 915 11. Pathogenesis, Genetics, and Genomics of Non–High Grade Serous Ovarian Cancers - p. 929 12. Diagnosis and Treatment of Ovarian Cancer - p. 943 13. Management and Treatment of Recurrent Epithelial Ovarian Cancer - p. 965 14. Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer - p. 983 15. Targeting DNA Damage Response and Repair as a Therapeutic Strategy for Ovarian Cancer - p. 997 16. Treatment of Rare Epithelial Ovarian Tumors - p. 1011 17. Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer - p. 1025 18. Targeting Angiogenesis: Taming the Medusa of Ovarian Cancer - p. 1041 19. Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer - p. 1057 20. Living Through Ovarian Cancer Treatment: Acute and Long-Term Toxicities of Chemotherapy for Advanced-Stage Disease - p. 1073 21. Palliative Care and Symptom Management for Women with Advanced Ovarian Cancer - p. 1087
No hay muestra disponible
No hay ficha técnica disponible
